Influenza

The new vaccine is expected to be available for the 2020-2021 influenza season.

Fewer than 2% of all patients hospitalized with pneumonia in 2014 received the vaccination.

Xofluza is currently being evaluated in a phase 3 development program for the reduced transmission of flu from an infected person to healthy people.

The CDC Influenza Division medical director reported new findings at IDWeek showing older patients with influenza subtype A were more likely to be hospitalized.

New findings presented at IDWeek show vaccinated children have inconsistent protection from the A(H3N2) flu subtype.

How a community-based assessment can show physicians the ways in which the flu spreads.

The CDC Influenza Division medical officer discusses findings from their pediatric assessment at IDWeek.

A pair of phase 3 trials show the single-dose oral drug could have expanded benefits for influenza, just months before an sNDA ruling.

Early research found that e-cigarette use affects the immune system response to the flu virus and the effects are different for female and male users.

As providers, we do not want to scare parents into worrying about every cough or fever. Not every illness is sepsis.

A new 5-point clinical decision guideline could make it easier for emergency department physicians to determine which patients warrant a flu test.

The American Academy of Pediatrics says the nasal spray is an acceptable option for influenza vaccination in the coming flu season.

Investigators observed a 22% and 20% increased risk of heart failure during the 2 most severe influenza seasons.

Modeling showed that waiting until October to vaccinate would reduce flu cases in older adults, provided vaccination rates don’t decrease and flu season doesn’t peak early.

Flu tracking estimates that don’t consider behavioral differences between different demographic groups will tend to underestimate the spread of the flu, a new study reports.

Patients who received a flu shot had a lower rate of myocardial infarction, according to new research.

University of Colorado study finds choline can help prevent fetal brain development problems in expecting mothers who experience illness.

A prospective study of over 500 patients found those with influenza A had more severe symptoms and slower recovery than those with influenza B.

An FDA decision on the application is expected by December 27, 2019.

The Genentech therapy is currently the first and only single-dose oral medicine marketed for flu treatment, and was the first new flu medicine with a novel mechanism of action in 2 decades.

Researchers say a new challenge virus didn’t lead to influenza in as many patients as expected, but it will still yield valuable insights as researchers push to develop a universal flu vaccine.

A study suggests individuals who received egg-based flu vaccines had less protection against circulating strains of influenza than those with cell-based vaccines in the 2017-2018 season.

By identifying epitopes that are common to all types of the flu, researchers believe they may have created a pathway to a universal flu vaccine.

New research based on 8 flu seasons’ worth of data supports the early use of oseltamivir, particularly in cases of A(H3N2) influenza.

As people age, their B cells become less adaptive, leaving them more susceptible to the flu.

Each flu season, the race is on to determine how well the flu vaccine is working. But researchers caution that many of the studies used to calculate effectiveness have potential pitfalls.

New research shows women who are pregnant face a higher risk of ending up in the hospital, regardless of pregnancy stage.

A new CDC study found the flu vaccine was 38% effective last year, but it also stopped more than 100,000 hospitalizations.

Patients with influenza-like illness face a higher risk of stroke up to a year after infection.

Flu vaccination reduced influenza-related hospitalizations by 38% among patients with COPD.